人工智慧如何改變糖尿病照護
How AI is changing diabetes care
Updated at: June 7, 2026 at 04:30 AM
人工智慧正從根本上改變我們管理糖尿病的方式，將重點從被動的定期檢查轉移到持續且個人化的支援。
Artificial intelligence is fundamentally changing how we manage diabetes, shifting the focus from reactive, periodic check-ins to continuous, personalized support.
由於糖尿病管理極度仰賴血糖濃度和胰島素劑量等可量化數據，因此它是人工智慧創新的理想領域。
Because diabetes management relies heavily on quantifiable data like blood glucose levels and insulin doses, it is an ideal field for AI innovation.
自動胰島素輸送（AID）系統等技術扮演著人造胰臟的角色，利用演算法即時調整胰島素，大幅減輕了病患的心理負擔。
Technologies like Automated Insulin Delivery (AID) systems act as an artificial pancreas, using algorithms to adjust insulin in real-time, which significantly reduces the mental burden on patients.
除了日常管理外，人工智慧也徹底改變了診斷方式。
Beyond daily management, AI is revolutionizing diagnostics.
現在，相關工具能在幾年前就預測糖尿病風險，並透過分析視網膜影像，在幾分鐘內偵測出糖尿病視網膜病變等併發症。
Tools can now predict diabetes risk years in advance and detect complications like diabetic retinopathy by analyzing retinal images in minutes.
此外，具備人工智慧功能的應用程式能簡化日常任務，例如從食物照片估算碳水化合物含量，讓糖尿病患者的生活更輕鬆。
Furthermore, AI-powered applications help simplify daily tasks, such as estimating carbohydrate content from food photos, making life easier for those living with the condition.
儘管仍存在諸如人工智慧決策過程模糊（亦即「黑箱」問題），以及數據隱私與公平性等疑慮，但整合這些技術仍至關重要。
While challenges like the 'black box' problem—where AI decision-making remains opaque—and concerns regarding data privacy and equity persist, the integration of these technologies is essential.
隨著全球糖尿病盛行率攀升，人工智慧提供了護理領域必要的演進，在病患自主管理與專家醫療指導之間搭起橋樑，確保世界各地的病患擁有更高效且具支援性的未來。
As the global prevalence of diabetes rises, AI offers a necessary evolution in care, bridging the gap between patient self-management and expert medical guidance to ensure a more efficient and supportive future for patients everywhere.
